| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $133,768,455 ) (Continued on the next page) |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI174932 | Rapid Tests for Recent Infection (RTRI) for Precision Public Health in Sub-Saharan Africa: Next-Generation Strategies Amid Changing HIV Epidemiology | 000 | 3 | NIH | 10/28/2024 | $720,426 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01DA055758 | Beyond Treatment Initiation: Enhancing Opioid Use Disorder Care Transitions Across Health System Touchpoints | 000 | 3 | NIH | 4/11/2025 | $179,898 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K24HL165161 | Mentoring the next generation of trainees in patient-oriented, community engaged research in obesity and health equity | 000 | 3 | NIH | 5/2/2025 | $126,872 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R00MH125878 | Identifying neural markers of risk for anxiety in infancy | 000 | 5 | NIH | 4/18/2025 | $203,215 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI162774 | Mechanisms of alphavirus infectivity and adaptation - Resubmission - 1 | 000 | 4 | NIH | 1/14/2025 | $523,814 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U2CCA271890 | Microbial and host biomarker development for detection and prognosis of early stage non-small cell lung cancer | 000 | 3 | NIH | 4/28/2025 | $917,627 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01DK132395 | Continuous allocation score design for guaranteeing equity and reducing discards in kidney and liver transplantation | 000 | 3 | NIH | 11/28/2024 | $623,463 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL171292 | EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease | 000 | 2 | NIH | 1/28/2025 | $684,618 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01HL096812 | ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | 001 | 14 | NIH | 3/21/2025 | $450,000 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01HL096812 | ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | 001 | 14 | NIH | 3/21/2025 | $2,702,426 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01HL096812 | ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | 001 | 14 | NIH | 3/21/2025 | $1,350,000 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U19NS107616 | Oxytocin Modulation of Neural Circuit Function and Behavior | 000 | 7 | NIH | 1/17/2025 | $75,719 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL157220 | Intradialytic Myocardial Stunning in Hemodialysis Patients - a Novel Cardiovascular Risk Factor | 000 | 4 | NIH | 11/8/2024 | $618,937 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K02AG076883 | Cognitive prehabilitation to prevent Alzheimer's disease after kidney transplantation | 000 | 3 | NIH | 11/14/2024 | $151,740 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01HL096812 | ARIC Neurocognitive Study (ARIC-NCS) Renewal 2023-2028 | 001 | 14 | NIH | 3/21/2025 | $1,442,613 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F31AI174615 | Characterization of the SARS-CoV-2-mediated piracy of p38ß | 000 | 2 | NIH | 11/15/2024 | $48,974 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 000 | 4 | NIH | 3/24/2025 | $49,871 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 000 | 4 | NIH | 3/24/2025 | $150,000 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | UC2AR081039 | Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT) | 000 | 4 | NIH | 3/24/2025 | $1,050,000 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG068142 | The role of brain border-associated macrophages in aging and cerebral amyloid angiopathy | 000 | 4 | NIH | 12/24/2024 | $573,132 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01CA260432 | Identification and characterization of cancer cell states by novel computational and experimental technologies - Resubmission - 1 | 001 | 4 | NIH | 4/16/2025 | $518,035 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R37AI038446 | Mechanisms of Pneumococcal Persistence During Carriage | 000 | 31 | NIH | 4/24/2025 | $610,200 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | U01AI174997 | Safety and efficacy of Belatacept in heart transplantation | 000 | 3 | NIH | 4/30/2025 | $1,710,716 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR080068 | Dermal Lymphatic Transport and Cutaneous Immune Balance | 000 | 4 | NIH | 12/20/2024 | $396,189 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01ES033160 | Chromatin assembly and formaldehyde toxicity | 000 | 4 | NIH | 12/27/2024 | $545,205 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AR083407 | Regulation of inflammation by the ubiquitin proteasome pathway | 000 | 2 | NIH | 12/18/2024 | $546,256 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL160891 | Chylomicrons and endothelial biology | 000 | 3 | NIH | 12/18/2024 | $745,095 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA266212 | mRNA stability and its impact on hematopoiesis and acute leukemia | 000 | 4 | NIH | 12/18/2024 | $486,121 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K99DC021581 | Neural circuitry and population dynamics for perception of social vocalizations in the auditory pathway | 000 | 2 | NIH | 1/21/2025 | $160,089 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R21AI182931 | Mechanisms of anemia in malaria | 000 | 2 | NIH | 4/16/2025 | $211,875 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EB035129 | HRV-guided tDCS: Integrating a biomarker for clinical utility | 000 | 2 | NIH | 4/18/2025 | $690,895 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL173157 | Investigating Donor Authorization and Public Perceptions of Normothermic Regional Perfusion to Inform Ethical Organ Donation Practices | 000 | 2 | NIH | 4/15/2025 | $675,987 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01EY033353 | Neurotoxicity of Reactive Astrocyte-secreted Lipids in Neurodegenerative Disease | 000 | 4 | NIH | 1/22/2025 | $466,245 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K23MH134068 | Deep Learning Based Natural Language Processing Markers of Anxiety and Depression | 000 | 3 | NIH | 5/2/2025 | $196,956 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS133751 | Inhibitory and Disinhibitory VIP Interneuron-Mediated Circuits in Neocortex | 000 | 3 | NIH | 5/1/2025 | $648,370 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA293718 | Targeting cell state transitions driving resistance to KRAS inhibitors in lung cancer | 000 | 2 | NIH | 4/29/2025 | $646,432 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI170583 | Viral disruption of host transcriptome integrity | 000 | 3 | NIH | 1/14/2025 | $500,146 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS120488 | Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models | 000 | 3 | NIH | 1/15/2025 | $731,440 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01HL166418 | The Function of Mammalian LPGAT1 | 000 | 3 | NIH | 1/22/2025 | $464,930 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | K01DK139420 | Neighborhood Characteristics and Chronic Kidney Disease Incidence/Progression: A Quasi-Experimental Study | 000 | 2 | NIH | 4/9/2025 | $155,222 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | F30HL167568 | The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease | 000 | 3 | NIH | 3/7/2025 | $53,974 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01NS127129 | The Neural Circuit Basis of Olfactory Navigation in Adult Drosophila | 000 | 2 | NIH | 3/12/2025 | $550,595 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AG077422 | Alzheimer’s Disease Related Biomarkers following SARS-CoV-2 Infection | 000 | 4 | NIH | 3/13/2025 | $1,250,283 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018528 | Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations | 001 | 3 | NIH | 3/31/2025 | $694,908 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA251669 | Adhesion GPCR regulation of acute myeloid leukemia stem cells - Resubmission - 1 | 000 | 5 | NIH | 2/13/2025 | $541,230 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01AI158687 | Determinants of induced Treg and inflammatory Th17 cell balance in response to potentially pathogenic microbiota | 000 | 5 | NIH | 2/13/2025 | $505,444 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018018 | Do no digital harm? A multilevel evaluation of technology-facilitated team care on the patient-provider relationship in health disparity populations | 001 | 3 | NIH | 4/15/2025 | $672,560 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01MD018018 | Do no digital harm? A multilevel evaluation of technology-facilitated team care on the patient-provider relationship in health disparity populations | 003 | 3 | NIH | 4/17/2025 | $0 |
| | 2025 | 2025 | NEW YORK UNIVERSITY | 550 1ST AVE | NEW YORK | NY | 10016-6402 | NEW YORK | USA | R01CA282437 | Combining CDK7 and MUC1-C inhibition to target different subtypes of small cell lung cancer | 000 | 2 | NIH | 2/13/2025 | $606,509 |
|
